PyInvesting

Market research

300149.SHE Chempartner Pharmatech Co., Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
5B
P/E ratio
Not available
Analyst target
14.94
Dividend yield
Not available
Beta
0.75

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Chempartner Pharmatech Co., Ltd is currently in a long term uptrend where the price is trading 5.6% above its 200 day moving average.

From a valuation standpoint, the stock is 54.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.

Chempartner Pharmatech Co., Ltd's total revenue rose by 17.7% to $399M since the same quarter in the previous year.

Its net income has increased by 32.8% to $42M since the same quarter in the previous year.

Finally, its free cash flow grew by 441.3% to $31M since the same quarter in the previous year.

Based on the above factors, Chempartner Pharmatech Co., Ltd gets an overall score of 5/5.